Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1

Orphanet Journal of Rare Diseases
Andreas SelberherrBruno Niederle

Abstract

Patients with multiple endocrine neoplasia type 1 (MEN-1) develop multiple pancreatic neuroendocrine neoplasias (PNENs). Size at diagnosis and growth during follow-up are crucial parameters. According to the WHO 2017, grading is another important parameter. The impact of grading compared to size (WHO 2000) on the clinical course needs to be evaluated. Sixty PNENs of six patients with MEN-1 were retrospectively evaluated. Fifty-one tumors with a diameter of < 20 mm were graded as G1. Two of 9 tumors with diameters of ≥20 mm were graded as G2. Tumor size of ≥20 mm correlated significantly with higher proliferation (p = 0.000617). Lymph node metastases were documented in two patients with a total of 19 tumors. In one patient, all 13 tumors (diameter: 0.4 to 100 mm) were classified as G1. However, metastases were documented in 9/29 lymph nodes. In the other patient, 5 tumors (3.5 to 20 mm) were classified as G1. The sixth tumor (30 mm) was classified as G2 (Ki-67: 8%). Metastases were revealed in 2/20 lymph nodes. Tumor size of ≥20 mm seems to correlate with more aggressive MEN-1 related pancreatic disease, regardless of individual proliferation. Tumors ≥20 mm and tumors graded as G2 should be treated surgically regardless of their...Continue Reading

References

Jul 27, 2001·Best Practice & Research. Clinical Endocrinology & Metabolism·P G Gauger, N W Thompson
Mar 27, 2002·Langenbeck's Archives of Surgery·Göran AkerströmBritt Skogseid
May 21, 2003·Journal of Internal Medicine·G M Doherty, N W Thompson
Sep 1, 1958·The American Journal of Medicine·J V VERNER, A B MORRISON
May 22, 2004·Annals of the New York Academy of Sciences·Günter KlöppelPhilipp U Heitz
May 9, 2006·World Journal of Surgery·Maria A KouvarakiNancy D Perrier
May 16, 2006·The American Journal of Surgical Pathology·Martin AnlaufGünter Klöppel
Sep 13, 2006·Virchows Archiv : an International Journal of Pathology·G RindiUNKNOWN European Neuroendocrine Tumor Society (ENETS)
Aug 9, 2007·Virchows Archiv : an International Journal of Pathology·Günter KlöppelPaul Komminoth
Apr 28, 2010·Virchows Archiv : an International Journal of Pathology·Günter KlöppelDavid S Klimstra
Mar 3, 2012·World Journal of Surgery·Mark A LewisWilliam F Young
Apr 25, 2012·Journal of the National Cancer Institute·G RindiB Wiedenmann
Mar 10, 2016·World Journal of Surgery·Caroline L LopezDetlef K Bartsch
Aug 25, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Guido RindiIan A Cree

❮ Previous
Next ❯

Methods Mentioned

BETA
pancreatectomy
dissection

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J T Pang, Rajesh V Thakker
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
M HorgerK Müssig
© 2022 Meta ULC. All rights reserved